$37.02
0.0250.07%
Last update: Oct 26, 12:49 PM
Agios Pharmaceuticals Inc (AGIO) Stock Price, Quote, News & History
AGIONASDAQ
Agios Pharma (AGIO) stock spikes 15% as FDA grants Priority Review for sickle cell disease drug mitapivat. Details here.
You can purchase shares of Agios Pharmaceuticals (NASDAQ:AGIO) through any online brokerage.
Other companies in Agios Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Agios Pharmaceuticals has a consensus price target of $45.42.
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $37.025 last updated October 26, 2026 at 12:49 PM EDT.
There are no upcoming dividends for Agios Pharmaceuticals.
Agios Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Agios Pharmaceuticals.
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially...
